Seegene is a leading developer of multiplex molecular assays and automated solutions for US clinical labs
What You Need to Know About SARS-CoV-2 Variant Tracking - Omicron, BA.2 Omicron and others
Tracking, researching, and responding to variants is now an important part of our global health response to the COVID-19 pandemic. Understanding the implications of these different mutations (and their combined impact) is a key part of this strategy.
Seegene's response to the Omicron Variant
Introducing Seegene Mobile Station
High Multiplex RT-PCR Testing for COVID-19 and Other Pathogens
Seegene Allplex™ and Novaplex™ Assays
Allplex™ 2019-nCoV (SARS-CoV-2) Assay
Novaplex™ SARS-CoV-2 / FluA / FluB / RSV Assay*
Novaplex™ SARS-CoV-2 Variants Assays*
* Research Use Only
COVID-19: Find the solution that's right for you...
Blog & Press Releases
Published on: PR Newswire SEOUL, South Korea, March 17, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced the appointment of Glen Hansen, Ph.D., D(ABMM), FCCM, as
Published on: PR Newswire SEOUL, South Korea, March 2, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced the appointment of Richard S. Creager, Ph.D., as the